CClinicalTrials.gg
CompletedNCT04436757IPS_FIRAHUpdated Jul 31, 2025

Self and Body-esteem in Socio-professional Rehabilitation

An interventional study of IPS program : Self-image and body representation and TAU in Schizophrenia, Bipolar Disorder and Personality Disorders, sponsored by Hôpital le Vinatier. Completed at 1 site in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-07-31.

Sponsored by Hôpital le Vinatier · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The body esteem influences the physical appearance, which can be a social brake. To enhance the socio-professional insertion of persons with severe mental disorders, the investigators developed a group program about self-presentation and body esteem. The study's objective is to understand the body esteem impact on socio-professional insertion, and how to improve that with a dedicated group program, for patients in a psychosocial rehabilitation center

Read the detailed description

Our hypothesis is that a group program centered on the image and the presentation of the self, with the intervention of professionals of the image of the body, such as socio-hairdresser, socio-beautician, allows a better socio-professional inclusion, through an improvement in body self-esteem. Taking care of yourself will require different approaches such as advice on hygiene, becoming aware of your body, experimenting with beauty treatments and having the means to reproduce them at home. We will compare our IPS program (Image and Presentation of Self), with the usual management in the care center (TAU = "Treatment As Usual")

02

Conditions studied

  • Schizophrenia
  • Bipolar Disorder
  • Personality Disorders
  • Anxiety Disorders
  • Depressive Disorder

Keywords

  • severe mental disorders
  • body-esteem
  • body-representation
  • self-esteem
  • socio-professional insertion
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 33 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Hôpital le Vinatier is the lead sponsor of 106 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18 to 65.
  • Speaking French.
  • Diagnosis of severe mental disorders (MSD) established according to the criteria of the DSM-V (Diagnostic and Statistical Manual of Mental Disorders) such as: Schizophrenia, Bipolar Disorders, Serious Personality Disorders, Severe Anxiety Disorders, Depressive Disorders; with a clinical stability of more than 3 months.
  • Supported at SUR/CL3R with an application for socio-professional reintegration.
  • Guardian agreement (for persons under guardianship);
  • Information given to the curator (for persons under curatorship);
  • Member of the social security scheme.

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of Autism Spectrum Disorder (ASD) or Eating Behaviour Disorder.
  • Clinical status incompatible with group activity.
  • Acute episode in progress.
  • Refusal to participate.
  • Simultaneous participation in a psycho-social rehabilitation program targeting image or self-esteem (general and/or body).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    IPS (Self-image and body-representation program)

    The IPS program (Self-image and body representation) was designed by Dr PLAZAT and coll. for specific use with patients with severe mental disorders suffering of low self- and body-esteem and aiming at " reinsert themselves" in the society.

    Behavioral: IPS program : Self-image and body representation

  • Active comparator
    TAU

    Treatment As Usual : the usual care proposed by the health service (SUR/CL3R).

    Behavioral: TAU

Interventions

  • BehavioralIPS program : Self-image and body representation

    The IPS program consists in 13 sessions of 2 hours over a 13-weeks period. Sessions content is as follows : 1. : Introduction 2. : Sensory approach workshop 3. : Self presentation and personal hygiene 4. : Organisation of well-being, planning and pictograms 5. : Becoming aware of my body, my envelope 6. : Presentation and self-esteem (photolanguage) 7. : Self-presentation in social interactions: Social codes 8. : My ideas and desires for change 9. : Places of well-being and clothing hygiene 10. : Vocational insertion devices 11. : Daring change : presence of a Socio-hairdresser 12. : The awakening of color : presence of a Socio-aesthetician 13. : Development of practice sheets and the network

  • BehavioralTAU

    The treatment of the group TAU (Treatment As Usual) will consist of the usual care proposed by the health service. No additional session will be proposed.

06

What researchers measure

Primary outcomes

  1. Appreciation of one's own appearance

    The main judgement criterion is the difference before/after the program for each of the two groups (IPS and TAU) of the weighted average at the "satisfaction with overall appearance" and "wish to change appearance" dimensions of the BES (Body-Esteem Scale), common dimensions for men and women. This difference will be compared between the 2 groups by a Student test (or a Wilcoxon-Mann-Whitney test in case of non normality).

    Time frame: baseline, one month, three months, nine months after the end of the treatment

Secondary outcomes

  1. Appreciation of the Self-esteem measured by the Self-Esteem Rating Scale

    As for the primary outcome

    Time frame: baseline, one month, three months, nine months after the end of the treatment

  2. Appreciation of the well-being measured by the Warwick-Edinburgh Well-Being Mental Scale

    As for the primary outcome

    Time frame: baseline, one month, three months, nine months after the end of the treatment

  3. Appreciation of the satisfaction level measured by the Client's Assessment of Strengths, Interests and Goals Scale (CASIG )

    As for the primary outcome

    Time frame: baseline, one month, three months, nine months after the end of the treatment

  4. Appreciation of the satisfaction measured by the Satisfaction in the domains of life

    As for the primary outcome

    Time frame: baseline, one month, three months, nine months after the end of the treatment

07

Study locations

1 site
  • centre de réhabilitation - Hôpital le Vinatier
    Lyon, Rhône 69006, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04436757
Lead sponsor
Hôpital le Vinatier
Responsible party
Sponsor
First posted
Jun 18, 2020
Start date
Jun 22, 2020
Primary completion
Oct 17, 2023
Completion
Oct 17, 2023
Last update
Jul 31, 2025

Study contacts

Lucie-Orianne PLAZAT, M.D
principal investigator · Centre Hospitalier le Vinatier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion